DNMBP-AS1 Axis Boosts Immunotherapy by Blocking Cancer Metabolism
In a groundbreaking study poised to redefine therapeutic strategies for colorectal cancer, researchers have identified a novel molecular axis that not only suppresses tumor progression but also significantly enhances the efficacy of immune checkpoint blockade therapy. Central to this discovery is the DNMBP-AS1/hsa-miR-30a-5p/PGC1α regulatory pathway, which intervenes in cancer metabolism and immune response, offering a […]
In a groundbreaking study poised to redefine therapeutic strategies for colorectal cancer, researchers have identified a novel molecular axis that not only suppresses tumor progression but also significantly enhances the efficacy of immune checkpoint blockade therapy. Central to this discovery is the DNMBP-AS1/hsa-miR-30a-5p/PGC1α regulatory pathway, which intervenes in cancer metabolism and immune response, offering a […]
What's Your Reaction?
